SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-10-036758
Filing Date
2010-07-07
Accepted
2010-07-07 14:29:44
Documents
2
Period of Report
2010-07-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FLU rrd280999.htm 8-K 12910
2 PRESS RELEASE, DATED JULY 7, 2010, TITLED "DYNAVAX INITIATES FIRST HUMAN TRIAL I rrd280999_32371.htm EX-99.1 8621
  Complete submission text file 0001181431-10-036758.txt   23044
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 10941684
SIC: 2834 Pharmaceutical Preparations